Dr. Reddy's Laboratories
GA - Norcross
TOLCAPONE (tolcapone) by Dr. Reddy's Laboratories is catechol o-methyltransferase inhibitors [moa]. Approved for catechol-o-methyltransferase inhibitor [epc]. First approved in 2018.
Drug data last refreshed 21h ago
Catechol O-Methyltransferase Inhibitors
Catechol-O-Methyltransferase Inhibitor
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Short-term Effects of TOLCAPONE on Transthyretin Stability in Subjects With Leptomeningeal TTR Amyloidosis (ATTR)
A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of Tolcapone
Worked on TOLCAPONE at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.